These findings further support the role of vascular remodeling and hemodynamic changes, alongside molecular alterations such as FGFR1 and CDKN2A polymorphisms, in influencing HCC progression and prognosis [24]. The gene discussed is FGFR1; the disease is hepatocellular carcinoma.